Selective COX-2 inhibition improves endothelial function in coronary artery disease.

Circulation

Volumn 107, Issue 3, 2003, Pages 405-409

  Chenevard, Rémy ^a   Hürlimann, David ^a   Béchir, Markus ^a   Enseleit, Frank ^a   Spieker, Lukas ^a   Hermann, Matthias ^a   Riesen, Walter ^a   Gay, Steffen ^a   Gay, Renate E ^a   Neidhart, Michel ^a   Michel, Beat ^a   Lüscher, Thomas F ^a   Noll, Georg ^a   Ruschitzka, Frank ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CELECOXIB; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; ISOENZYME; LOW DENSITY LIPOPROTEIN; MEMBRANE PROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; PTGS2 PROTEIN, HUMAN; PYRAZOLE DERIVATIVE; SULFONAMIDE;

AGED; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG ANTAGONISM; DRUG EFFECT; ECHOGRAPHY; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; VASCULAR ENDOTHELIUM; VASODILATATION;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CORONARY ARTERIOSCLEROSIS; CROSS-OVER STUDIES; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DOUBLE-BLIND METHOD; ENDOTHELIUM, VASCULAR; HUMANS; ISOENZYMES; LIPOPROTEINS, LDL; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYRAZOLES; SULFONAMIDES; VASODILATION;

EID: 0037469296     PISSN: None     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/01.CIR.0000051361.69808.3A     Document Type: Article

References (0)